SCHEMBL31053001

SCHEMBL31053001

CC(C)c1nccc(/C=C/C(=O)O)c1N.CC(C)c1nccc(/C=C/C(=O)OC(C)(C)C)c1N

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.36
▸ HTT P42858 2/20 0.35
▸ LMNA P02545 1/20 0.35
▸ NR1I2 O75469 1/20 0.35
▸ PGR P06401 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ ADORA3 P0DMS8 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ SLC6A2 P23975 1/20 0.35
▸ TBXAS1 P24557 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ DRD3 P35462 1/20 0.35
▸ OPRK1 P41145 1/20 0.35
▸ PDE4D Q08499 1/20 0.35
▸ KCNH2 Q12809 1/20 0.35
▸ MAP3K7 O43318 2/20 0.33
▸ TAB1 Q15750 2/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ ESR1 P03372 2/20 0.31
▸ GAA P10253 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29671322 0.95 HTT (0.37) HTTLMNANR1I2PGRCYP3A4
SCHEMBL22848034 0.95 HTT (0.37) HTTLMNANR1I2PGRCYP3A4
SCHEMBL28680459 0.88 KDM4E (0.41) KDM4EHTTMAP3K7TAB1MAPK1
SCHEMBL22848333 0.73 LMNA (0.43) KDM4EHTTLMNANR1I2PGR
SCHEMBL29671313 0.73 LMNA (0.43) KDM4EHTTLMNANR1I2PGR
SCHEMBL5457635 0.72 CA1 (0.51) KDM4EHTTLMNANR1I2PGR
SCHEMBL5457639 0.72 CA1 (0.51) KDM4EHTTLMNANR1I2PGR
SCHEMBL16486856 0.69 KDM4E (0.43) KDM4EHTTLMNANR1I2PGR
SCHEMBL16486858 0.69 KDM4E (0.43) KDM4EHTTLMNANR1I2PGR
SCHEMBL23693838 0.69 HRH4 (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114008037-B Heterocyclic compounds as KRAS G12C inhibitors 广东新契生物医药科技有限公司 2024-06-21 — — CN disclosed
Send feedback